SK

Srihari Kaligithi

Active Director Additional Director DIN 10144477
DIN 10144477 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Srihari Kaligithi

Data last updated:

Srihari Kaligithi is an Additional Director at Reichindia Pharma Limited (since 2023). The company operates in Pharma. Reichindia Pharma Limited reported revenue of ₹9.54 Cr (FY 2022).

DIN 10144477
Primary Designation Additional Director
Industry Pharma
First Appointment 02 May 2023
Oldest Company Age 31 yrs
Largest company Reichindia Pharma Limited · ₹9.54 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Reichindia Pharma Limited U24230TG1995PLC021457
Additional Director02 May 20231995₹9.54 Cr (FY 2022)Active

Board colleagues of Srihari Kaligithi

NameDINCompanyDesignation
Tulasi Venkata Ramana Murthy10145800Reichindia Pharma LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Reichindia Pharma Limited
Premium access

Shareholding and investment profile for Srihari Kaligithi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srihari Kaligithi

Srihari Kaligithi currently holds 1 directorship: Reichindia Pharma Limited (Additional Director, since 02 May 2023, revenue ₹9.54 Cr (FY 2022)).

Srihari Kaligithi was first appointed on 02 May 2023 as Additional Director at Reichindia Pharma Limited.

The current boards of Srihari Kaligithi's companies include Tulasi Venkata Ramana Murthy (Reichindia Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available